Potential therapeutic targets in ARID1A -mutated cancers one of the highest mutation rates across different human
cancer types. For example, ARID1A is mutated
Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro by flow cytometry, the activity of
signaling pathways in cells treated with CBL0137 was determined by real
Statins synergize with hedgehog pathway inhibitors for treatment of medulloblastoma© 2018 American Association for
Cancer Research. Purpose: The role of cholesterol biosynthesis
Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy apoptosis, activation of epidermal growth factor receptor
signaling pathway, etc. This article summarizes
Potential therapeutic targets in ARID1A -mutated cancers one of the highest mutation rates across different human
cancer types. For example, ARID1A is mutated
Long non-coding RNAs as promising biomarkers and therapeutic targets in cervical cancerBegliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal , metabolism,
signaling
pathways, and apoptosis. LncRNAs molecules are highly stable due to their small size
S‑Glutathionylation and S‑Nitrosylation as Modulators of Redox-Dependent Processes in Cancer Cell the status and direction of
signaling pathways in
cancer cells. The review discusses the features of S